Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Rheumatology

Managing Organ Involvement and Long-Term Monitoring

At a Glance

Proactive monitoring is essential to protect your internal organs when living with systemic sclerosis. Regular pulmonary function tests (PFTs) check for lung disease, while daily at-home blood pressure monitoring is the single most important way to catch a potentially dangerous renal crisis early.

Systemic sclerosis (SSc) is a multisystem disease, meaning it can affect several internal organs. Because many of these changes happen “silently” before you feel symptoms, proactive monitoring is the most powerful tool you have to protect your long-term health [1][2]. Today, the leading causes of mortality in SSc are lung-related—specifically lung scarring (interstitial lung disease) and high blood pressure in the lung arteries (pulmonary arterial hypertension) [3][4].

Protecting Your Lungs

Lung involvement is common, but it can often be managed if caught early.

  • Interstitial Lung Disease (SSc-ILD): This is a process where the lung tissue becomes scarred (fibrotic). Doctors monitor this using Pulmonary Function Tests (PFTs), specifically looking at your FVC (forced vital capacity) and DLCO (diffusing capacity) [5][6].
    • Monitoring: PFTs are typically done every 3 to 6 months in the early years of the disease [5].
    • The Gold Standard: A High-Resolution Computed Tomography (HRCT) scan is used to get a detailed “snapshot” of the scarring [7].
  • Pulmonary Arterial Hypertension (PAH): This is high blood pressure in the arteries of the lungs. Because it can be hard to catch with a standard ultrasound of the heart (echocardiogram) alone, doctors use the DETECT algorithm [5].
    • The DETECT Algorithm: This is a specialized, multi-step screening tool that combines PFT results, blood tests, and an echocardiogram to determine if you need a “right heart catheterization” to confirm a PAH diagnosis [8][9].

The “Silent” Crisis: Scleroderma Renal Crisis (SRC)

Historically, kidney failure was the top cause of death in SSc. This changed with the discovery of ACE inhibitors (like lisinopril), which are now the gold-standard treatment for Scleroderma Renal Crisis (SRC) [10][11].

  • Your Role at Home: SRC can happen very quickly. Daily at-home blood pressure monitoring is the single most important thing you can do to catch it early [12].
  • Red Flags: A sudden rise in blood pressure, even if it is still within the “normal” range (e.g., jumping from 100/60 to 135/85), can be a warning sign [13].
  • Treatment, Not Prevention: If SRC occurs, your medical team will use aggressive doses of ACE inhibitors to protect your kidneys [14]. However, it is critical to know that ACE inhibitors should NOT be taken in advance to prevent SRC. Research shows that taking them prophylactically can actually lead to worse outcomes or mask the early warning signs of a crisis [15][16].

Gastrointestinal (GI) Involvement

The GI tract is affected in nearly 90% of SSc patients [17]. The goal is to manage symptoms and ensure you are getting proper nutrition.

  • Reflux and Dysmotility: Scarring can slow down the esophagus and intestines, leading to severe heartburn or “gastroparesis” (food staying in the stomach too long) [17].
  • Monitoring: Doctors may use manometry (measuring muscle contractions) or breath tests to check for Small Intestinal Bacterial Overgrowth (SIBO) [17][18].
  • Lifestyle Management: For severe reflux, foundational lifestyle changes are crucial. This includes elevating the head of your bed and avoiding eating within 3 hours of lying down [17].

Your Surveillance Checklist

This general schedule helps ensure no organ system is overlooked [2][1].

Frequency Test / Action What it Checks
Daily At-Home Blood Pressure Kidney Health (SRC)
Every 3–6 Months Pulmonary Function Tests (PFTs) Lung Scarring (ILD)
Every 6–12 Months Echocardiogram / DETECT Lung Pressure (PAH)
Annually Blood Work (NT-proBNP, Creatinine) Heart and Kidney Function
As Needed HRCT Scan / GI Studies Detailed Organ Assessment

Common questions in this guide

Why do I need to monitor my blood pressure daily with systemic sclerosis?
Daily blood pressure monitoring is the most important way to catch Scleroderma Renal Crisis (SRC) early. A sudden rise in your blood pressure, even if it stays within a normal range, can be a critical warning sign that requires immediate medical evaluation.
Should I take ACE inhibitors to prevent a scleroderma renal crisis?
No, you should not take ACE inhibitors to prevent a renal crisis. Research shows that taking them in advance can mask early warning signs or lead to worse outcomes, though they are the standard treatment if a crisis actually occurs.
How do doctors check for lung involvement in systemic sclerosis?
Doctors typically use Pulmonary Function Tests (PFTs) every 3 to 6 months to monitor your lung capacity and detect early scarring. They may also use a High-Resolution Computed Tomography (HRCT) scan to get a detailed, diagnostic picture of your lung tissue.
What is the DETECT algorithm used for?
The DETECT algorithm is a specialized, multi-step screening tool that combines blood tests, lung function tests, and an echocardiogram. It helps doctors accurately assess your risk for high blood pressure in the lungs (pulmonary arterial hypertension).
How can I manage severe heartburn caused by systemic sclerosis?
For severe reflux and delayed stomach emptying, foundational lifestyle changes are crucial. This includes elevating the head of your bed and avoiding eating within three hours of lying down to prevent stomach acid from traveling up your esophagus.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the schedule for my lung function tests (PFTs), and how do we decide when another HRCT scan is necessary?
  2. 2.Am I considered high-risk for a renal crisis, and what should my specific blood pressure target be for home monitoring?
  3. 3.Can we use the DETECT algorithm for my next pulmonary hypertension screening?
  4. 4.Are there specific gastrointestinal symptoms I should watch for that might indicate my GI involvement is progressing?
  5. 5.If my blood pressure spikes at home, should I take an extra dose of medication or go straight to the emergency room?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    [Systemic sclerosis-clinical picture, diagnosis, and treatment].

    Becker MO, Distler O, Maurer B

    Zeitschrift fur Rheumatologie 2019; (78(5)):439-457 doi:10.1007/s00393-019-0639-2.

    PMID: 31089800
  2. 2

    Systemic sclerosis.

    Volkmann ER, Andréasson K, Smith V

    Lancet (London, England) 2023; (401(10373)):304-318 doi:10.1016/S0140-6736(22)01692-0.

    PMID: 36442487
  3. 3

    [From renal crisis to lung fibrosis - systemic sclerosis in the course of time].

    Jahns KM, Dreher M, Triantafyllias K, et al.

    Deutsche medizinische Wochenschrift (1946) 2025; (150(16)):975-979 doi:10.1055/a-2615-9127.

    PMID: 40763754
  4. 4

    French recommendations for the management of systemic sclerosis.

    Hachulla E, Agard C, Allanore Y, et al.

    Orphanet journal of rare diseases 2021; (16(Suppl 2)):322 doi:10.1186/s13023-021-01844-y.

    PMID: 34304732
  5. 5

    Spectrum of Clinical Manifestations in Patients of Scleroderma and Correlation between Cutaneous and Pulmonary Involvement.

    Oak J, Unavane O, Mathur R

    The Journal of the Association of Physicians of India 2025; (73(3)):17-20 doi:10.59556/japi.73.0855.

    PMID: 40087926
  6. 6

    Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management.

    Mirsaeidi M, Barletta P, Glassberg MK

    Frontiers in medicine 2019; (6()):248 doi:10.3389/fmed.2019.00248.

    PMID: 31737640
  7. 7

    Interstitial lung disease in Indonesian adult with systemic sclerotic: A rare case.

    Anggoro A, Hasan H

    Annals of medicine and surgery (2012) 2022; (75()):103386 doi:10.1016/j.amsu.2022.103386.

    PMID: 35242329
  8. 8

    An Update on Systemic Sclerosis and its Perioperative Management.

    Carr ZJ, Klick J, McDowell BJ, et al.

    Current anesthesiology reports 2020; (10(4)):512-521 doi:10.1007/s40140-020-00411-8.

    PMID: 32904358
  9. 9

    Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertension.

    Launay D, Sanges S, Sobanski V

    The European respiratory journal 2021; (57(6)) doi:10.1183/13993003.00205-2021.

    PMID: 34168056
  10. 10

    Autoantibodies in systemic sclerosis overlap syndrome and their correlation with organ damage and survival.

    Wang F, Li C, Li X, et al.

    Annals of medicine 2024; (56(1)):2407526 doi:10.1080/07853890.2024.2407526.

    PMID: 39348269
  11. 11

    African Americans and Scleroderma: Examining the Root Cause of the Association.

    Morgan ND, Gelber AC

    Arthritis care & research 2019; (71(9)):1151-1153 doi:10.1002/acr.23860.

    PMID: 30821891
  12. 12

    Spectrum of renal disease in scleroderma other than scleroderma renal crisis: A review of the literature.

    Farrukh L, Steen V, Shapiro L, et al.

    Clinical nephrology 2024; (102(2)):97-106 doi:10.5414/CN111243.

    PMID: 38699985
  13. 13

    Scleroderma Renal Crisis in a Normotensive Patient.

    Asamoah-Odei E

    Kidney international reports 2016; (1(4)):311-315 doi:10.1016/j.ekir.2016.07.005.

    PMID: 29318207
  14. 14

    Renal Involvement in Systemic Sclerosis: An Update.

    Chrabaszcz M, Małyszko J, Sikora M, et al.

    Kidney & blood pressure research 2020; (45(4)):532-548 doi:10.1159/000507886.

    PMID: 32521536
  15. 15

    ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis.

    Bütikofer L, Varisco PA, Distler O, et al.

    Arthritis research & therapy 2020; (22(1)):59 doi:10.1186/s13075-020-2141-2.

    PMID: 32209135
  16. 16

    Kidney involvement in systemic sclerosis: From pathogenesis to treatment.

    Bruni C, Cuomo G, Rossi FW, et al.

    Journal of scleroderma and related disorders 2018; (3(1)):43-52 doi:10.1177/2397198318758607.

    PMID: 35382123
  17. 17

    Esophageal dysmotility in systemic sclerosis: Relationship with extra-gastrointestinal manifestations and complementary utility of thoracic imaging.

    Santos I, Marques-Gomes C, Diz-Lopes M, et al.

    Journal of scleroderma and related disorders 2025; 23971983251362586 doi:10.1177/23971983251362586.

    PMID: 40787593
  18. 18

    The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis.

    Stec A, Maciejewska M, Paralusz-Stec K, et al.

    Journal of inflammation research 2023; (16()):1895-1904 doi:10.2147/JIR.S409489.

    PMID: 37152867

This page provides educational information on systemic sclerosis organ monitoring. Always consult your rheumatologist or specialist care team for medical advice and to establish your personalized monitoring schedule.

Get notified when new evidence is published on Systemic sclerosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.